MOLNMolecular Partners AG American Depositary Shares
4.400USDMkt Cap: 165.05M $P/E: —3d ago
Molecular Partners AG, a clinical-stage biotechnology company, designs and develops designed ankyrin repeat proteins therapeutics for the treatment of oncology diseases in Switzerland. Its product pipeline comprises MP03…
Industry Peers
BiotechnologyKey Statistics
Company
Market Cap165.05M $
Enterprise Value83.25M $
Revenue (TTM)—
Gross Profit-36.66M $
Net Income (TTM)-61.65M $
Revenue/Share—
Last Price4.400 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees134
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-16.41
PEG—
EV/EBITDA-1.60
EV/Revenue—
P/S—
P/B1.88
EPS (TTM)-1.91
EPS (Forward)-0.26
52W Range
4.380100% of range4.400
52W High4.400 USD
52W Low4.380 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-76.74%
ROA-60.38%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-51.26M $
CapEx (TTM)714.00K $
FCF Margin—
FCF Yield-15.27%
Net Debt-75.42M $
Net Debt/EBITDA1.45
Balance Sheet
Debt/Equity0.05
Current Ratio9.43
Quick Ratio9.21
Book Value/Sh2.253 USD
Cash/Share2.100 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)11.24 USD
Upside (mean)+155.4%
Target Range3.788 USD – 17.14 USD
$3.788+155.4% to mean$17.14
# Analysts5
Ownership
Shares Out.37.51M
Float19.92M
Insiders0.00%
Institutions9.58%
Short Interest
Short Ratio0.3d
Short % Float0.01%
Short % Out.0.00%
Shares Short1.39K
Short (prev mo.)1.75K
Technical
SMA 503.997 (+10.1%)
SMA 2004.228 (+4.1%)
Beta0.68
S&P 52W Chg21.00%
Avg Vol (30d)483
Avg Vol (10d)560
Technical Indicators
RSI (14)64.9
MACD0.0871
MACD Signal0.0633
MACD Hist.+0.0238
BB Upper4.419 USD
BB Middle4.124 USD
BB Lower3.828 USD
BB Width14.34%
ATR (14)0.0894 USD
Vol Ratio (20d)0.53x